Piracetam Sodium Chloride Injection

1. Pharmacological action This product is a brain metabolism improving drug, which is a cyclic derivative of г-aminobutyric acid. It has an effect of resisting brain function damage caused by physical and chemical factors. It can promote the generation of ATP in the brain, promote the synthesis of acetylcholine and enhance the conduction of nerve excitation, and has the effect of promoting brain metabolism. It can resist brain function damage caused by physical and chemical factors. It has an improvement effect on retrograde amnesia caused by hypoxia. It can enhance memory and improve learning ability. 2. Toxicological study The acute toxicological test of animal experiments showed that the oral dose of mice was greater than 10g/kg, and no death was found. The median lethal dose LD50 of intravenous administration is 9.2g/kg. Subacute and chronic toxicological experiments did not find any adverse effects on the growth and development of rats and dogs. It has no effect on important internal organs and functions such as blood, heart, liver, kidney, and brain.

The main ingredient of this product is piracetam. Its chemical name is: 2-oxido-1-pyrrolidinoacetamide. Excipients: sodium chloride, water for injection.

This product is a colorless clear liquid.

It is suitable for memory loss and mild to moderate brain dysfunction caused by various reasons such as acute and chronic cerebrovascular diseases, brain trauma, various toxic encephalopathy, etc. It can also be used for children with intellectual retardation.

Intravenous drip: 4-8 g each time, once a day.

1. Adverse reactions of the central nervous system include nervous excitement, irritability, hyperactivity, dizziness, headache, sleep disorders (insomnia, drowsiness) and depression, but the symptoms are mild and have nothing to do with the dosage. The above symptoms disappear after stopping the drug. 2. Common adverse reactions of the digestive tract include nausea, abdominal discomfort, poor appetite, abdominal distension, abdominal pain, weight gain, diarrhea, etc. The severity of the symptoms is directly related to the dosage. 3. Mild liver damage is occasionally seen, manifested as mild increase in aminotransferase, but it is unrelated to the drug dosage. 4. Occasionally, skin rash is seen

1. Patients with extrapyramidal diseases and Huntington's chorea are prohibited from using this product to avoid aggravating the symptoms. 2. Pregnant women are prohibited from using this product. 3. Newborns are prohibited from using this product. 4. Patients with severe liver and kidney dysfunction are prohibited from using this product. 5. Patients who are allergic to the ingredients of this product are prohibited from using this product.

Precautions for children: Not for newborns. Precautions for pregnancy and lactation: This product easily crosses the placental barrier, so it is not for pregnant women. The indication for use in lactating women is not clear. Precautions for the elderly: Not yet clear.

When this product is used in combination with warfarin, it can prolong the prothrombin time and induce the inhibition of platelet aggregation. In patients receiving anticoagulant therapy, special attention should be paid to the coagulation time when piracetam is used at the same time to prevent the risk of bleeding, and the dosage and usage of the anticoagulant therapy should be adjusted.

Keep away from light and store in a sealed container.

100ml:20g

Tentative 24 months

Jiangsu Morning Brand Pharmaceutical Group Co., Ltd.

• Founded in:

  1996-05-28

• Address:

  No. 666, Beijing East Road, Haimen District, Nantong City, Jiangsu Province

• Tax NO.:

  913206001388073171

• Registered Funds:

  55 million yuan

• Website:

  Log in to view

• Email:

  Log in to view